Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
![](/images/homepage_main_image.png)
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is July 17, 2024.
All times in Eastern Daylight Time.
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NYSE Arca Biotechnology UCITS ETF 16.07.2024 FBTU.LN IE00BL0L0H60 300,002.00 ... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Capital Strength UCITS ETF 16.07.2024 FTCS. IE00BL0L0D23 300,002.00 USD 8,886... more »
-
CLACTON-ON-SEA, England--(BUSINESS WIRE)--Pickering Interfaces, the leading supplier of modular signal switching and simulation solutions for use in electronic test and verification, today announce... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 16.07.2024 FVD. IE00BKVKW020 625,002.00 U... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 16.07.2024 FCSG IE00BKPSPT20 77... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 16.07.2024 FXGB LN IE00BD5HBR05 87,992.00 GBP 1,567,586.35... more »
-
Rockwell Automation Announces New Chief Financial OfficerMILWAUKEE--(BUSINESS WIRE)--Rockwell Automation (NYSE:ROK), the world’s largest company dedicated to industrial automation and digital transformation, today announced that Christian Rothe will join... more »
-
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust FactorFX UCITS ETF 16.07.2024 FTFX IE00BD5HBQ97 38,402.00 USD 901,109.33 23.4... more »
-
Lookout Named a Leader in Mobile Threat Defense Solutions by Independent Research FirmBOSTON--(BUSINESS WIRE)--Lookout, Inc., the data-centric cloud security company, today announced it has been named a leader in The Forrester Wave™: Mobile Threat Defense Solutions, Q3 2024 report. ... more »
-
TME Pharma kündigt mündliche Präsentation der Phase 1/2-Studie NOX-A12 GLORIA bei Glioblastom auf dem ESMO-Kongress 2024 anBERLIN--(BUSINESS WIRE)--TME Pharma N.V. (Euronext Growth Paris: ALTME), ein Biotechnologieunternehmen im klinischen Stadium, das sich auf die Entwicklung neuartiger Krebstherapien konzentriert, di... more »
-
The Oasis Group Releases AI WealthTech Map as Resource for Wealth Management FirmsMONROE TOWNSHIP, N.J.--(BUSINESS WIRE)--The Oasis Group, a leading consultancy for the wealth management industry, today released their AI WealthTech Map, a resource that financial advisors and wea... more »
-
Anaconda Biomed Receives IDE Approval to Initiate Enrollment in the ATHENA StudyBARCELONA, Spain--(BUSINESS WIRE)--Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems, has announced that it has received conditional IDE approval fr... more »
-
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2024 after the market closes on Wednesday, July 24, 2024, and... more »
-
Meliora Therapeutics Announces Appointment of Biopharma Luminaries to Board of DirectorsSAN FRANCISCO--(BUSINESS WIRE)--Meliora Therapeutics (“Meliora”), a machine learning therapeutics company developing novel and transformative cancer drugs, today announced the appointment of Dieter... more »